Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Neurology Rheumatology Diabetes / Metabolic Mental Health / Psychiatry Women's Health Dermatology Men's Health Rare Diseases
Clinical Trial ● Currently Recruiting Non-phase study NCT07431021

Children’s Health, Respiratory Inflammation and Short-term Air Pollution

Children’s Health, Respiratory Inflammation and Short-term Air Pollution — Recruiting • Non-phase study • Respiratory / COPD / Asthma • NCT07431021.

📅 21 Apr 2026 ⏱ 1 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
Phase
Non-phase study
NCT ID
NCT07431021
Sponsor
Queen Mary University of London
Start
2025-10-20
ClinicaliQ Trial Snapshot
  • Children’s Health, Respiratory Inflammation and Short-term Air Pollution — Recruiting • Non-phase study • Respiratory / COPD / Asthma • NCT07431021.
  • What is being tested: Whether physical activity during periods of high air pollution exposure causes greater respiratory inflammation in children compared to remaining at rest in the same polluted conditions.
  • Patient eligibility overview: The trial involves children as the primary study population, though specific age ranges, health status criteria, and geographic/pollution level requirements would be defined in the full protocol.
Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

The goal of this study is to see if physical activity in high air pollution is worse than rest in high air pollution.

Eligibility Snapshot
  • : * Attending schools in Central and East London that have been recruited to the study

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Guideline
Digital technologies for applying algorithms to spirometry to support asthma and COPD diagnosis in primary care and community diagnostic centres: early-use assessment
Respiratory / COPD / Asthma · 02 Apr 2026
Digital spirometry algorithms can improve diagnostic accuracy for asthma and COPD in primary care and community diagnostic centres, potentially reducing unnecessary referrals…
View guideline →
Guideline
2021 ESCMID Guidelines for the Management of Community-acquired Pneumonia
Respiratory / COPD / Asthma · 30 Mar 2026
This ESCMID guideline addresses 2021 ESCMID Guidelines for the Management of Community-acquired Pneumonia in Respiratory / COPD / Asthma. Use it to…
View guideline →
Guideline
Digital technologies to support self-management of asthma: early-use assessment
Respiratory / COPD / Asthma · 05 May 2026
Use digital asthma self-management tools (apps, web platforms, wearables) as adjuncts to standard care to help patients monitor symptoms, track triggers, and…
View guideline →
Clinical Brief
Short-acting beta 2 agonists (SABA) (salbutamol and terbutaline): reminder of the risks from overuse in asthma and to be aware of changes in the SABA prescribing guidelines
Respiratory / COPD / Asthma · MHRA · 24 Apr 2025
Healthcare professionals and patients are reminded of the risk of severe asthma attacks and increased mortality associated with overuse of SABA with…
View brief →
Guideline
Bronchiectasis (non-CF): Diagnosis and Management (NICE NG117)
Respiratory / COPD / Asthma · 27 Mar 2026
Suspect bronchiectasis in patients presenting with chronic productive cough or recurrent respiratory infections and refer for High-Resolution CT chest imaging; investigate all…
View guideline →
Clinical Brief
Norovirus cases remain high while respiratory viruses fall
Respiratory / COPD / Asthma · UKHSA · 05 Mar 2026
Norovirus circulation remains elevated despite seasonal decline in respiratory viruses, warranting continued vigilance for gastroenteritis outbreaks in healthcare and community settings Respiratory…
View brief →